We are an international healthcare provider. We provide care that is valued by
our patients and stakeholders by focusing on our employees, clinicians, clinical
excellence, using analytics and technology to positively impact the care we deliver.
We are committed to being a good corporate citizen and conducting our business
ethically and sustainably.
Our geographic footprint spans across southern Africa, the United Kingdom and Europe.
International healthcare
provider
Offering an integrated
healthcare model and diagnostic
imaging capability
Diversified
offering
With a growing share of
revenue and earnings from
non-acute sources
Clinical excellence,
analytics and technology
Focus on our employees,
clinicians, clinical excellence and
using analytics and technology
to positively impact patient care
Our vision
Our vision is to be an international healthcare provider delivering measurable clinical
quality through a diversified offering and people-centred approach.
Leadership reviews
Chairman's review
It has been an extraordinary challenging time to step in as the Life Healthcare
Chairman. Almost two years have passed since COVID-19 was declared a pandemic
by the World Health Organization (WHO).
Dr Victor Litlhakanyane
Chairman
Exceptional
Alliance Medical Group
performance
REVENUE
up 21.0%
NORMALISED EBITDA
up 40.7%
Group Chief Executive's review
This financial year was particularly unpredictable, as we navigated our way through second and third COVID-19 waves, as well as experiencing widespread civil unrest in KwaZulu-Natal and Gauteng during July 2021.
Peter Wharton-Hood
Group Chief Executive (GCE)
Over the financial period,
the commitment, spirit,
and dedication of all our
employees, doctors,
healthcare professionals
and stakeholders in our
business has been
unwavering. For this I want
to express my utmost and
sincere gratitude.
Group Chief Financial Officer's review
Life Healthcare’s 2021 financial year has incorporated a full 12 months of COVID-19-related effects, including two severe COVID-19 waves which severely disrupted trading for the Group.
Pieter van der Westhuizen
Group Chief Financial Officer (CFO)
GROUP REVENUE
increased by
12.7% to
DISTRIBUTION OF
R26.9 BILLION
Normalised EBITDA increased
by 21.6% to
R5.1 BILLION